Lam Research Corporation $LRCX Shares Sold by Zhang Financial LLC

Zhang Financial LLC lowered its position in Lam Research Corporation (NASDAQ:LRCX) by 6.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,455 shares of the semiconductor company’s stock after selling 282 shares during the period. Zhang Financial LLC’s holdings in Lam Research were worth $434,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. New York Life Investment Management LLC increased its stake in shares of Lam Research by 0.8% during the second quarter. New York Life Investment Management LLC now owns 192,258 shares of the semiconductor company’s stock worth $18,714,000 after purchasing an additional 1,472 shares in the last quarter. Private Wealth Partners LLC purchased a new stake in shares of Lam Research during the second quarter worth about $847,000. Howard Capital Management Inc. increased its stake in shares of Lam Research by 11.0% during the second quarter. Howard Capital Management Inc. now owns 34,720 shares of the semiconductor company’s stock worth $3,388,000 after purchasing an additional 3,434 shares in the last quarter. Motley Fool Asset Management LLC increased its stake in shares of Lam Research by 14.5% during the second quarter. Motley Fool Asset Management LLC now owns 81,686 shares of the semiconductor company’s stock worth $7,951,000 after purchasing an additional 10,347 shares in the last quarter. Finally, May Hill Capital LLC increased its stake in shares of Lam Research by 6.5% during the second quarter. May Hill Capital LLC now owns 8,570 shares of the semiconductor company’s stock worth $834,000 after purchasing an additional 520 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Stock Performance

Lam Research stock opened at $155.62 on Wednesday. The firm has a 50 day simple moving average of $125.50 and a 200-day simple moving average of $101.30. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $158.24. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The stock has a market cap of $195.46 billion, a price-to-earnings ratio of 34.28, a price-to-earnings-growth ratio of 1.64 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the prior year, the company posted $0.86 EPS. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were paid a $0.26 dividend. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Wednesday, September 24th. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is currently 22.91%.

Wall Street Analysts Forecast Growth

LRCX has been the subject of a number of research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $170.00 target price on shares of Lam Research in a research note on Thursday, October 23rd. Citigroup boosted their target price on shares of Lam Research from $120.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Susquehanna boosted their target price on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. Hsbc Global Res raised shares of Lam Research to a “hold” rating in a research note on Tuesday, September 30th. Finally, Raymond James Financial upped their price objective on shares of Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $148.83.

Insider Activity at Lam Research

In other news, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This represents a 13.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.